PPT-Why, when & How to add Prandial insulin after Basal Optimization

FOCUS OF PROFILE GLULISINE The main target To normalize Blood glucose Delay progression Reduce complication s Diabetes Management ᵛ ᵛ fasting postprandial 1Fasting hyperglycemia . in Creating Brain-Like Intelligence, . Sendhoff. et al.. Course: Robots Learning from Humans. Kim, Jung Ah. College of Natural Sciences. Interdisciplinary Program in Brain Science. Seoul National University. G. lucose . C. ontrol. Mary Catherine . MacSween. MD FRCPC. The Moncton Hospital . Case DM. 74 year old male DM1 x 40 years.. MDI with . Levemir. 17 units . hs. and . NovoRapid. at meals.. Pre-op instructions take half usual . Program Overview. Pathophysiology of Hyperglycemia. Updated ADA/EASD Standard of Care, 2017. Delays in Intensification of Therapy. The Role of Basal Insulin and GLP-1 RA in Controlling Hyperglycemia. Andrew Maclennan, MD April 23, 2010 Morning Report. & Insulin Autoimmune Syndrome (Hirata disease). Symptoms of hypoglycemia. “. Neuroglycopenic. symptoms”. Cognitive impairment, behavioral changes, psychomotor abnormalities, coma, death. Disclaimers. Program Goals. Initiation of Insulin Significantly Delayed in Many Patients. Percentage of Patients Achieving Glycemic Targets in Various Settings. Sequential Insulin Strategies in Type 2 Diabetes. Program Goals. The . Incretin System: Response to Oral Glucose. Injected Incretin-based Agents: GLP-1 Receptor Agonists. Oral Incretin-based Agents: DPP-4 Inhibitors . Main Pathophysiological Defects in T2D. August 18, 2017. Disclaimer. This activity features cases that are loosely based on two famous musicians who had diabetes: Jerry Garcia and Ella Fitzgerald. Publicly available medical information was used to construct the core elements of the cases. When information was not available, the activity content planners added relevant, but fictional, details to devise an meaningful educational experience.  . Novelty 1: Ice thickness is allowed to vary during the optimization (but constrained by observational uncertainties) to provide another degree of freedom. Probabilistic Sea-Level Projections from Ice Sheet and Earth System Models 3:  Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . Melissa Ashdown BSN, CDE, CPT. G. Denise Cooks, MSN, CPNP-PC, CDE, CPT. Objectives. Understand the difference between Continuous Glucose Monitors and Insulin Pumps. Describe hyperglycemia and hypoglycemia. A Amouzegar, MD. Endocrine Research Center, Research Institute For Endocrine Sciences, Shahid Beheshti University, Tehran . Agenda. Rationale for Early Insulin Therapy. Which insulin is appropriate for being initiated?. Diabetes Educator. Program Coordinator . Diabetes Resource Center . Hopkinsville, KY.. Disclosure. to Participants. Notice of Requirements For Successful Completion. Please refer to learning goals and objectives. Research Institute For Endocrine Sciences. Endocrine Research Center. Shahid Beheshti University. 04.04.1397. Outlines. Case presentation. Barriers of insulin therapy. Action-profile. Types of basal .